1 Min Read
March 20 (Reuters) - Strongbridge Biopharma Plc:
* STRONGBRIDGE BIOPHARMA ANNOUNCES ISSUANCE OF PATENT FOR RECORLEV™ (LEVOKETOCONAZOLE) FOR THE TREATMENT OF CUSHING’S SYNDROME Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.